Angiomics is a biotechnology start-up specializing in the production of vascularized human tissue, including microvasculature tissue. The fully vascularized 3-D tissue provides an ideal platform for both drug discoveries and testing through phenotypic screening, enabling faster and more efficient discoveries of new compounds.